Atlas Trials

Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican Participants

Clinical trial NCT04311463 · COMPLETED

Trial details

NCT number
NCT04311463
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Anxiety Disorders
Start date
2020-12-09
Primary completion
2021-01-02
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.